Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $232.02 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $185.50 | 8 | $0 (2024) |
| Avanos Medical | $32.50 | 2 | $0 (2023) |
| Allergan Inc. | $14.02 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $173.50 | 7 | Novo Nordisk Inc ($173.50) |
| 2023 | $32.50 | 2 | Avanos Medical ($32.50) |
| 2022 | $12.00 | 1 | Novo Nordisk Inc ($12.00) |
| 2017 | $14.02 | 1 | Allergan Inc. ($14.02) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.46 | General |
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.42 | General |
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $98.86 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.83 | General |
| 07/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.90 | General |
| 05/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.70 | General |
| 02/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.33 | General |
| 02/24/2023 | Avanos Medical | GENERATOR (Device) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/24/2023 | Avanos Medical | GENERATOR (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/10/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.00 | General |
| 04/05/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 14 | 16 | $5,808 | $1,086 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 16 | $5,808 | $1,086 | 18.7% |
About Dr. Wazim Buksh, MD
Dr. Wazim Buksh, MD is a Sports Medicine healthcare provider based in East Hanover, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2011. The National Provider Identifier (NPI) number assigned to this provider is 1073893442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wazim Buksh, MD has received a total of $232.02 in payments from pharmaceutical and medical device companies, with $173.50 received in 2024. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($232.02).
As a Medicare-enrolled provider, Buksh has provided services to 14 Medicare beneficiaries, totaling 16 services with total Medicare billing of $1,086. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Internal Medicine
- Location East Hanover, NJ
- Active Since 08/17/2011
- Last Updated 06/30/2020
- Taxonomy Code 207RS0010X
- Entity Type Individual
- NPI Number 1073893442
Products in Payments
- Wegovy (Drug) $98.86
- GENERATOR (Device) $32.50
- DALVANCE (Drug) $14.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.